Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Most peptides degrade rapidly in the body, but BPC-157 remains active long enough to exert therapeutic effects
It is a signaling peptide
AOD-9604 was advanced through Phase I and Phase II clinical trials by Metabolic Pharmaceuticals between roughly 2003 and 2007 enrolling approximately 900 participants in total
Joshua Berkowitz, ensures that each patient receives personalized care and attention
With growing evidence on synergy, it's a promising tool for healthspan extension
US$ 26.32
US$ 29.74
:max_bytes(150000):strip_icc()/GettyImages-1325156535-67466a48bddf41e8b271fcf573650026.jpg)
US$ 25.75
US$ 24.09
US$ 21.52
US$ 22.45
.webp)
US$ 25.03
